Rigel Pharmaceuticals reported $149.07M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acura Pharmaceuticals ACUR:US 1.9M 22K
Agenus AGEN:US $ 441.3M 24.65M
Amgen AMGN:US $ 59196M 1969M
Anika Therapeutics ANIK:US $ 342.24M 5.3M
Applied Genetic Technologies AGTC:US $ 87.19M 5.18M
Arrowhead Research ARWR:US $ 703.58M 65.04M
Astrazeneca AZN:US $ 100273M 5090M
AstraZeneca AZN:LN 100273M 5090M
Biomarin Pharmaceutical BMRN:US $ 6062.71M 59.38M
Bristol Myers Squibb BMY:US $ 103034M 6280M
Celldex Therapeutics CLDX:US $ 424.04M 20.61M
Chemocentryx CCXI:US $ 440.45M 14.8M
Daiichi Sankyo 4568:JP Y 2221402M 57930M
Eli Lilly And LLY:US $ 46919.3M 1886.7M
Halozyme Therapeutics HALO:US $ 1162.25M 57.82M
Heron Therapeutics HRTX:US $ 273.72M 31.98M
Immunogen IMGN:US $ 481.71M 44.06M
Intrexon XON:US $ 335.57M 24.29M
Karyopharm Therapeutics KPTI:US $ 294.03M 11.27M
Ligand Pharmaceuticals LGND:US $ 1105.18M 192.41M
Macrogenics MGNX:US $ 271.44M 63.8M
Regeneron Pharmaceuticals REGN:US $ 26348.7M 913.9M
Rigel Pharmaceuticals RIGL:US $ 149.07M 18.25M
Sangamo Biosciences SGMO:US $ 654.31M 67.61M
Ultragenyx Pharmaceutical RARE:US $ 1384.03M 138.37M
Veracyte VCYT:US $ 1173.59M 14.24M